References​

Alwan, S., Reefhuis, J., Rasmussen, S.A., Olney, R.S., & Friedman, J.M. for the National Birth Defects Prevention Study. (2007). Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. New England Journal of Medicine, 356 (26), 2684–2692.

Bennett, H.A., Einarson, A., Taddio, A., Koren, G. & Einarson, T.R. (2004). Prevalence of depression during pregnancy: systematic review. Obstetrics and Gynecology, 103 (4), 698–709.

Chambers, C.D., Hernandez-Diaz, S., Van Marter, L.J., Werler, M.M., Louik, C., Kenneth Lyons Jones, K.L. et al. (2006). Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. New England Journal of Medicine, 354 (6), 579–587.

Cox, J.L., Holden, J.M. & Sagovsky, R. (1987). Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. British Journal of Psychiatry, 150, 782–786.

GlaxoSmithKline. (n.d.). Paroxetine and pregnancy. Retrieved from www.gsk.com/en-gb/media/resource-centre/paroxetine/paroxetine-and-pregnancy

Goodman, S.H. & Gotlib, I.H. (1999). Risk for psychopathology in the children of depressed mothers: A developmental model for understanding mechanisms of transmission. Psychology Review, 106 (3), 458–490.

Louik, C., Lin, A.E., Werler, M.M., Hernandez-Diaz, S. & Mitchell, A.A. (2007). First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects. New England Journal of Medicine, 356 (26), 2675–2683.

Misri, S., Reebye, P., Kendrick, K., Carter, D., Ryan, D., Grunau, R.E. et al. (2006). Internalizing behaviors in 4-year-old children exposed in utero to psychotropic medications. American Journal of Psychiatry, 163 (6), 1026– 032.

Moses-Kolko, E.L., Bogen, D., Perel, J., Bregar, A., Uhl, K., Levin, B. et al. (2005). Neonatal signs after late in utero exposure to serotonin reuptake inhibitors. Journal of the American Medical Association, 293 (19), 2372–2383.

Sanz, E.J., De-las-Cuevas, C., Kiuru, A., Bate, A. & Edwards, R. (2005). Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: A database analysis. The Lancet, 365 (9458), 482–487.

Weissman, M.M., Pilowsky, D.J., Wickramaratne, P.J., Talati, A., Wisniewski, S.R., Fava, M. et al. (2006). Remissions in maternal depression and child psychopathology: A STAR*D-child report. Journal of the American Medical Association, 295 (12), 1389–1398. Erratum in: Journal of the American Medical Association (2006), 296 (10), 1234.